The Georgia Cancer Center Grand Rounds series features talks on mature cancer-related basic, translational, clinical, or population, prevention, and control research projects.

This series is expected to raise awareness of the great work being done within the Georgia Cancer Center and potentiate expanded interactions and collaborations with colleagues, not just from within the Georgia Cancer Center but from the entire university as well as other institutions.

Our weekly Research in Progress seminar series is a forum for our faculty to present current research from their laboratories. Research areas include basic science/translational, clinical, and behavioral/prevention science related to cancer. The research presented can be at any stage of development, including the earliest stages, where the background and hypotheses are strong, but data are incomplete. The purpose of these talks is to stimulate discussion, generate constructive feedback, and initiate collaboration.

Accreditation:

The Medical College of Georgia at Augusta University is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation:

The Medical College of Georgia at Augusta University designates this live activity for a maximum of [number of credits] AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact Us

Education and Training Office

Health Sciences Campus

Georgia Cancer Center - M. Bert Storey Research Building

Lisa Middleton

(706) 721-4566

lmiddleton@augusta.edu

2020 Schedule

Date Speaker Job Title/Position Institution Topic
July 1, 2020 Joseph M. Miano, PhD J. Harold Harrison, MD, Distinguished University Chair in Vascular Biology Augusta University Vascular Biology Center (AU) CRISPR Technology
July 8, 2020 Lauren Byers, MD, MS Associate Professor / Physician Scientist, Department of Thoracic and Head and Neck Medical Oncology MD Anderson Cancer Center Intratumoral Heterogeneity in Lung Cancer - Dissecting Drug Resistance
July 15, 2020 Andrew Futreal BS, PhD Department Chair, Department of Genomic Medicine, Division of Cancer Medicine MD Anderson Cancer Center Cancer heterogeneity – Challenges and Opportunities
July 22, 2020 Charles Sawyers, MD Chair, Human Oncology and Pathogenesis Program Memorial Sloan Kettering Cancer Center Lineage Plasticity and Cancer Drug Resistance
July 29, 2020 James Allison, PhD Chair, Department of Immunology, Division of Basic Science Research MD Anderson Cancer Center Immune Checkpoint Blockade in Cancer Therapy; New Insights into Therapeutic Mechanisms
August 5, 2020 John C. Hardaway, MD, PhD Surgical Oncologist Doctors Hospital of Augusta Regional Delivery of CAR-T; Strategies for Solid Tumor Immunotherapy
August 12, 2020 Daniel de Carvalho, PhD Canada Research Chair, Cancer Epigenetics Princess Margaret Cancer Centre Basic and Translational Aspects of Cancer Epigenetics – From Therapy to Liquid Biopsies
August 19, 2020 Gary A. Piazza, PhD Chief, Drug Discovery Research Center and Abraham A. Mitchell Distinguished Investigator, Professor of Oncologic Sciences and Pharmacology Mitchell Cancer Institute Novel RAS inhibitor class: a few unanswered questions
August 26, 2020 Walter J. Curran, Jr., MD, FACR, FASCO Executive Director Winship Cancer Institute Cancer Care and Research in the Time of COVID
Sept. 2, 2020 Jean-Pierre Issa, MD President and Chief Executive Officer Coriell Institute for Medical Research Next Generation Epigenetic Therapy
Sept. 9, 2020 Yan Cui, PhD Professor, Biochemistry and Molecular Biology Georgia Cancer Center CD73: a Pivotal Immune Checkpoint in the Tumor Microenvironment
Sept. 16, 2020 Keshav K. Singh, PhD Director, Cancer Genetics Program University of Alabama Comprehensive Cancer Center Mito-Nuclear Cross Talk Underlying Cancer 
Sept. 23, 2020 Paulo Rodriguez, PhD Associate Member Moffitt Cancer Center Restoring Protective Anti-tumor Immunity by targeting central mediators of Myeloid and T cell function
Sept. 30, 2020 Wendy Bollag, PhD, FAHA Professor of Physiology, VA Research Career Scientist Medical College of Georgia Phosphatidylglycerol-containing Surfaxin: A Possible Treatment for COVID-19 Pulmonary Failure?
October 7, 2020 Theodore S. Johnson, MD, PhD Associate Professor, Cancer Immunology, Inflammation & Tolerance Georgia Cancer Center IDO-based Multimodal Immuno-radio-chemotherapy for Pediatric Brain Cancer 
October 14, 2020 Vivian Wai Yan Lui, PhD Associate Professor Chinese University of Hong Kong Translational Genomics and Immonogenomics of Head and Neck Cancer
October 21, 2020 Kenneth C. Anderson, MD Program Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics Dana-Farber Cancer Institute Novel Therapies Targeting Myeloma in the Bone Marrow Microenvironment
October 28, 2020 Roni Bollag, MD, PhD Director, Georgia Cancer Center Biorepository Georgia Cancer Center Georgia Cancer Center Biorepository and the statewide Biobankinginitiative (BRAG-Onc) in 2020 
November 4, 2020 Chunhong Yan, PhD Member, Molecular Oncology and Biomarkers Program
Georgia Cancer Center Regulation of Metabolic Stress Response by a Common Stress Sensor
November 11, 2020 Asamoah Bosomtwi, PhD Director, MRI Imaging, Georgia Cancer Center Small Animal Imaging Shared Resource Georgia Cancer Center Quantitative and Qualitative Preclinical Imaging Capabilities at Georgia Cancer Center
November 18, 2020 Anatolij Horuzsko, MD, PhD Professor, Biochemistry and Molecular Biology Georgia Cancer Center TREM1 is a potential target for the treatment of liver diseases
December 2, 2020 Oliver Bogler, PhD Director, Center for Cancer Training National Cancer Institute Funding for Cancer Research Training from the NCI
December 9, 2020 Harikrishna Nakshatri, PhD Marian J. Morrison Professor of Breast Cancer Research Indiana University Impact of genetic ancestry on normal breast heterogeneity and breast cancer biology
December 16, 2020 Dongfang Liu, PHD, MBBS Associate Professor, Department of Pathology, Immunology &Laboratory Medicine, Center for Immunity and Inflammation New Jersey Medical School, Rutgers University Natural Killer Cells: from basic immunobiology to clinical application
January 6, 2021 Lei Zheng, M.D., Ph.D. Co-Director, Pancreatic Cancer Precision Medicine Center of Excellence Program Johns Hopkins Medicine Rationale Behind the Clinical Development of Combination Immunotherapy for Pancreatic Cancer
January 13, 2021 Andrew W. Truman, PhD Assistant Professor, Department of Biological Sciences University of North Carolina at Charlotte "Understanding Hsp70 interactions: new ways to
deal with difficult clients in cancer"
January 20, 2021 Douglas Spitz, PhD Director, Free Radical and Radiation Biology Program University of Iowa Health Care “Targeting Redox Metabolism for Cancer Therapy: From the Bench to the Bedside”
January 27, 2021 Besim Ogretmen, PhD Endowed Chair, SmartState Endowed Chair in Lipidomics and Drug Discovery Medical University of South Carolina "Sphingolipid metabolism and signaling in cancer therapeutics: Implications in aging, neurodegeneration and immunotherapy"
February 3, 2021 Huidong Shi, PhD Professor, Biochemistry and Molecular Biology Georgia Cancer Center "Epigenomics and Single Cell Sequencing Identifies Transcriptional Regulatory Networks That Control Resistance to Exhaustion and Antitumor Activity of CAR-T Cells"
February 10, 2021 Gideon E. Bollag, Ph.D. Chief Executive Officer Plexxikon “Structure Guided Strategies to Optimize Cancer Therapies”
February 17, 2021 Ming Luo, PhD Professor, Department of Chemistry Georgia State University "Armed Oncolytic Virus for Cancer Treatment"
February 24, 2021 Deyu Fang, MD/PhD Hosmer Allen Johnson Professor of Pathology Feinberg School of Medicine, Northwestern University "Sirt1 in immune regulation, inflammation and cancer: a tale of red wine"
March 3, 2021 John W Henson, MD Professor, Department of Neurology Georgia Cancer Center “Genetics and Precision Approaches in Neuro-oncology”